GL1X · GenesisL1 explorer

MolNFT v1 · #159491 · protein

Human lrh-1 bound to the agonist 6N and a fragment of the TIF2 coregulator

6OQY · Nuclear receptor subfamily 5 group a member 2: “Human lrh-1 bound to the agonist 6N and a fragment of the TIF2 coregulator”. X-ray diffraction, 1 ligand (N2J), 5 pockets (best druggability 0.85). MolNFT v1 #159491 on GenesisL1: 3D…

PDB
6OQY
Type
protein
Length
248 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Nuclear receptor subfamily 5 group a member 2; Nuclear receptor coactivator 2
UniProt
O00482, Q15596
Ligands
N2J
Pockets
5 · best druggability 0.85

Structure

x-ray diffraction · 2 distinct chains · 72% helix, 2% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ANuclear receptor subfamily 5 group a member 2protein23772% helix, 3% strandO00482
CNuclear receptor coactivator 2protein1173% helix, 0% strandQ15596

Ligands and binding sites

  • N2J · N-[(1S,3aR,6aR)-5-hexyl-4-phenyl-3a-(1-phenylethenyl)-1,2,3,3a,6,6a-hexahydropentalen-1-yl]sulfuric diamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13880.850.9333N2J
21160.680.9020empty
3550.340.7815empty
4560.330.7714empty
5720.320.7412empty

Interfaces

1 interface between chains.

  • A–C · 599 Ų buried · 9 hydrogen bonds · protein-protein

Compared structures

  • 6OQY · Human LRH-1 bound to the agonist 6N and a fragment of the Tif2 coregulator · the same entry in another collection · chain A against A, TM-score 1.00
  • O00482 · AlphaFold monomer V2.0 prediction for nuclear receptor subfamily 5 group a member 2… · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.